標題: Titlebook: Epstein Barr Virus Volume 2; One Herpes Virus: Ma Christian Münz Book 2015 The Editor(s) (if applicable) and The Author(s), under exclusive [打印本頁] 作者: FETUS 時間: 2025-3-21 19:08
書目名稱Epstein Barr Virus Volume 2影響因子(影響力)
書目名稱Epstein Barr Virus Volume 2影響因子(影響力)學科排名
書目名稱Epstein Barr Virus Volume 2網絡公開度
書目名稱Epstein Barr Virus Volume 2網絡公開度學科排名
書目名稱Epstein Barr Virus Volume 2被引頻次
書目名稱Epstein Barr Virus Volume 2被引頻次學科排名
書目名稱Epstein Barr Virus Volume 2年度引用
書目名稱Epstein Barr Virus Volume 2年度引用學科排名
書目名稱Epstein Barr Virus Volume 2讀者反饋
書目名稱Epstein Barr Virus Volume 2讀者反饋學科排名
作者: 無瑕疵 時間: 2025-3-21 23:09 作者: GIST 時間: 2025-3-22 01:58
Christian MünzHistorical reminiscence of Professor Sir Anthony Epstein on the discovery of EBV 50 years ago.32 comprehensive chapters on EBV virology, tumorigenesis and immune control.Newest insights on EBV strain 作者: 胡言亂語 時間: 2025-3-22 04:39
Current Topics in Microbiology and Immunologyhttp://image.papertrans.cn/e/image/313402.jpg作者: Lineage 時間: 2025-3-22 12:40 作者: Diluge 時間: 2025-3-22 15:41 作者: Diluge 時間: 2025-3-22 20:10 作者: CHIP 時間: 2025-3-23 01:07 作者: Critical 時間: 2025-3-23 04:57 作者: 極大痛苦 時間: 2025-3-23 08:57 作者: 慢慢沖刷 時間: 2025-3-23 12:19
Der Realismus des Neunzehnten Jahrhunderts,ionally regulate viral and/or cellular gene expression. With recent advances in RNA sequencing technologies, the list of identified EBV ncRNAs continues to grow. EBV-encoded RNAs (EBERs), the BamHI-A rightward transcripts (BARTs), a small nucleolar RNA (snoRNA), and viral microRNAs (miRNAs) are all 作者: 不要嚴酷 時間: 2025-3-23 14:59 作者: NOMAD 時間: 2025-3-23 19:35 作者: micturition 時間: 2025-3-23 22:48
On Measurement, Methodology and Systems,shows that EBV has developed powerful strategies and mechanisms to exploit, evade, abolish, or downsize otherwise effective immune responses to ensure its own survival. This chapter focuses on current knowledge on innate immune responses against EBV and its evasion strategies for own benefit and sum作者: 新奇 時間: 2025-3-24 05:12 作者: 阻塞 時間: 2025-3-24 09:41 作者: Pillory 時間: 2025-3-24 12:33 作者: LAPSE 時間: 2025-3-24 16:57
Annals of Theoretical Psychologybridization studies provided the first glimpses of the closely related herpesviruses that belonged to the same gamma-1 herpesvirus, or lymphocryptovirus, genus, as EBV. Over the years, detailed molecular and sequence analyses of LCVs that infect humans and other NHPs revealed similar colinear genome作者: 食草 時間: 2025-3-24 21:20
Gunnar Andersson,Gerard Radnitzkyrus establishes persistent infection in the majority of adult humans, but fortunately causes EBV-associated diseases only in few individuals. This is an incredible success story of the human immune system, which controls EBV infection and its transforming capacity for decades. A better understanding作者: 尋找 時間: 2025-3-25 02:07 作者: wangle 時間: 2025-3-25 06:18
EBNA2 and Its Coactivator EBNA-LPlatent EBV infection is the expression of several distinct and well-defined viral latent transcription programs called latency I, II, and III. Growth transformation of B-cells by EBV in vitro is based on the concerted action of Epstein-Barr virus nuclear antigens (EBNAs) and latent membrane proteins作者: GNAT 時間: 2025-3-25 08:46
The EBNA3 Family: Two Oncoproteins and a Tumour Suppressor that Are Central to the Biology of EBV inproliferate by the virus. Together with the other nuclear antigens (EBNA-LP, EBNA2 and EBNA1), they are expressed from a polycistronic transcription unit that is probably unique to B cells. However, compared with the other EBNAs, hitherto the EBNA3 proteins were relatively neglected and their roles 作者: OGLE 時間: 2025-3-25 13:52 作者: Lamina 時間: 2025-3-25 16:07
Latent Membrane Protein 2 (LMP2)quitin ligases and an ITAM that binds to SH2 domain-containing proteins, (b) a transmembrane domain with 12 transmembrane segments that localizes LMP2A in cellular membranes, and (c) a 27-amino acid C-terminal domain which mediates homodimerization and heterodimerization of LMP2 protein isoforms. Th作者: Deject 時間: 2025-3-25 20:06
EBV Noncoding RNAsionally regulate viral and/or cellular gene expression. With recent advances in RNA sequencing technologies, the list of identified EBV ncRNAs continues to grow. EBV-encoded RNAs (EBERs), the BamHI-A rightward transcripts (BARTs), a small nucleolar RNA (snoRNA), and viral microRNAs (miRNAs) are all 作者: 知識 時間: 2025-3-26 03:28
Viral Entryntry into these two cell types in vitro have been identified, and their roles in attachment and fusion are being explored. This chapter discusses what is known about entry at the cellular level in vitro and describes what little is known about the process in vivo. It highlights some of the questions作者: 精美食品 時間: 2025-3-26 05:17 作者: Lice692 時間: 2025-3-26 09:05 作者: 河流 時間: 2025-3-26 13:57
Epstein-Barr Virus-Specific Humoral Immune Responses in Health and Diseasedisease syndromes. Humoral immune responses to EBV have been studied for diagnostic, pathogenic and protective (vaccine) purposes. These studies use a range of methodologies, from cell-based immunofluorescence testing to antibody-diversity analysis using immunoblot and epitope analysis using recombi作者: 拱形面包 時間: 2025-3-26 19:37
T-Cell Responses to EBVion. Despite this high frequency of carriage, the virus causes apparently few adverse effects in the vast majority of infected individuals. Nevertheless, the potent growth transforming ability of EBV means the virus has the potential to cause malignancies in infected individuals. Indeed, EBV is thou作者: Sinus-Node 時間: 2025-3-26 22:53 作者: Adjourn 時間: 2025-3-27 01:45
Non-human Primate Lymphocryptoviruses: Past, Present, and Futurebridization studies provided the first glimpses of the closely related herpesviruses that belonged to the same gamma-1 herpesvirus, or lymphocryptovirus, genus, as EBV. Over the years, detailed molecular and sequence analyses of LCVs that infect humans and other NHPs revealed similar colinear genome作者: 馬賽克 時間: 2025-3-27 05:23
EBV Infection of Mice with Reconstituted Human Immune System Componentsrus establishes persistent infection in the majority of adult humans, but fortunately causes EBV-associated diseases only in few individuals. This is an incredible success story of the human immune system, which controls EBV infection and its transforming capacity for decades. A better understanding作者: legacy 時間: 2025-3-27 09:55 作者: IRATE 時間: 2025-3-27 15:00 作者: ANN 時間: 2025-3-27 18:44
EBNA2 and Its Coactivator EBNA-LP2 and EBNA-LP with EBNA1, EBNA3A, -3B, and -3C as well as LMP1, LMP2A, and LMP2B. The focus of this review will be to discuss the current understanding of how two of these proteins, EBNA2 and EBNA-LP, contribute to EBV-mediated B-cell growth transformation.作者: Melanoma 時間: 2025-3-27 22:59
Epstein-Barr Virus Lytic Cycle Reactivationn of viral progeny. In addition, the chapter highlights the potential role of lytic infection in disease development and current attempts to purposely induce lytic infection as a therapeutic approach.作者: 極大痛苦 時間: 2025-3-28 05:23 作者: Matrimony 時間: 2025-3-28 09:24 作者: CANON 時間: 2025-3-28 11:22 作者: bonnet 時間: 2025-3-28 14:47
0070-217X origenesis and immune control.Newest insights on EBV strain Epstein Barr virus (EBV) was discovered as the first human tumor virus around 50 years ago. Since its discovery in Burkitt’s lymphoma it has been associated with various other malignancies, infectious mononucleosis and even autoimmune disea作者: chapel 時間: 2025-3-28 18:50
Joachim Yahalom M.D.,Subhash Gulati is known about entry at the cellular level in vitro and describes what little is known about the process in vivo. It highlights some of the questions that still need to be addressed and considers some models that need further testing.作者: CARK 時間: 2025-3-29 00:54 作者: MURKY 時間: 2025-3-29 05:21
0070-217X y EBV. The assembled knowledge should help to understand EBV associated diseases better and to develop EBV specific vaccination in the near future.978-3-319-35834-5978-3-319-22834-1Series ISSN 0070-217X Series E-ISSN 2196-9965 作者: 勤勞 時間: 2025-3-29 09:35
Book 2015tinents for health care providers, biomedical researchers and patients that are affected by EBV. The assembled knowledge should help to understand EBV associated diseases better and to develop EBV specific vaccination in the near future.作者: INERT 時間: 2025-3-29 14:08
Carola Hilmes,Ilse Nagel schmidt3A and EBNA3C are necessary for the efficient proliferation of EBV-infected B cells because they target important tumour suppressor pathways—so operationally they are considered oncoproteins. In contrast, it is emerging that EBNA3B restrains the oncogenic capacity of EBV, so it can be considered a t作者: 冒號 時間: 2025-3-29 18:52
Anna of Denmark and Henrietta Mariawth of tumor cells. By acting like a constitutively active receptor, LMP1 recruits cellular signaling molecules associated with tumor necrosis factor receptors such as tumor necrosis factor receptor-associated factor (TRAF) proteins and TRADD to mimic signals of the costimulatory CD40 receptor in th作者: 管理員 時間: 2025-3-29 21:25
https://doi.org/10.1007/978-3-663-09270-4iated malignancies. While its antigenic properties may be useful in developing LMP2-specific immunity, the LMP2A N-terminal motifs also provide a basis to target LMP2A-modulated cellular kinases for the development of treatment strategies.作者: 去掉 時間: 2025-3-30 00:23
Der Realismus des Neunzehnten Jahrhunderts, are still unknown; however, roles for many EBV miRNAs in latency and in tumorigenesis have begun to emerge. Ongoing mechanistic studies to elucidate the functions of EBV ncRNAs should unravel additional roles for ncRNAs in the viral life cycle. In this chapter, we will discuss our current knowledge作者: STALE 時間: 2025-3-30 04:50
On Measurement, Methodology and Systems,immune responses against EBV by its main target cells, focusing on (i) EBV transmission between epithelial cells and B cells and their life cycle stages; and (ii) elements of innate immunity in EBV’s target cells. Further, we debate (II) the innate recognition and resulting innate immune responses a作者: 重力 時間: 2025-3-30 08:55 作者: 使成整體 時間: 2025-3-30 15:55
https://doi.org/10.1007/978-1-4613-3947-2ses, these diseases can be controlled by restoration of the T-cell compartment. In this chapter, we will primarily review the role the αβ subset of T cells in the control of EBV in healthy and diseased individuals.作者: 無表情 時間: 2025-3-30 18:15
https://doi.org/10.1007/978-1-4613-4243-4iral particles have been released. Preceding the adaptive immune response, potent innate immune mechanisms provide a first line of defense during primary and recurrent infections. In spite of this broad range of antiviral immune effector mechanisms, EBV persists for life and continues to replicate. 作者: 厚顏無恥 時間: 2025-3-31 00:20 作者: GLADE 時間: 2025-3-31 01:25
Gunnar Andersson,Gerard Radnitzky value of immune compartments during EBV infection, but also might provide a platform to test EBV-specific vaccines. This chapter will summarize the insights into EBV immunobiology that have already been gained in these models and provide an outlook into promising future avenues to develop this in v
